Journal article
The hidden threat: Primary care–driven strategies for earlier chronic kidney disease detection in Australia
Australian journal of general practice, Vol.55(3), pp.147-153
03/2026
PMID: 41785497
Appears in Recent Faculty of Health Publications
Metrics
1 Record Views
Abstract
Background: Chronic kidney disease (CKD) is a growing and underdiagnosed public health challenge. General practitioners are central to early detection, yet missed opportunities persist. Evidence suggests up to 90% of stage 3 CKD remains unrecorded, despite simple, cost-effective screening and treatment that slows progression. With a projected 39% rise in the number of Australians with stage 3–5 CKD by 2034, immediate action is required.
Objective: Three roundtable meetings were conducted across Australia with 35 primary care providers and kidney experts to identify barriers and supporting solutions to increase CKD detection and diagnosis.
Discussion: Six themes were identified to improve early CKD detection: (1) education, audits and supportive technologies; (2) guideline harmonisation and a unified risk calculator; (3) automated pathology integrated into practice software, linked to the CKD management in primary care handbook and decision tools; (4) defined CKD codes reflecting staging and cause; (5) multidisciplinary communication and models of care; and (6) government policy and advocacy to raise public awareness.
Details
- Title
- The hidden threat: Primary care–driven strategies for earlier chronic kidney disease detection in Australia
- Creators
- Ralph Audehm - The University of MelbourneKaren Dwyer - The Royal Melbourne HospitalAnita Muñoz - Royal Australian College of General PractitionersRoy Rasalam - Alfred HealthGraeme Turner - Northern NSW LHD (Australia, Lismore)Charlotte Hespe - The University of Notre Dame Australia
- Publication Details
- Australian journal of general practice, Vol.55(3), pp.147-153
- Publisher
- The Royal Australian College of General Practitioners
- Number of pages
- 7
- Grant note
- The logistics of the roundtable meetings and medical writing support were funded by AstraZeneca, Australia.
- Identifiers
- 991013372734002368
- Copyright
- © 2025 The Royal Australian College of General Practitioners (RACGP).
- Academic Unit
- Faculty of Health
- Language
- English
- Resource Type
- Journal article